Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT07633691
PHASE1

A Study to Exploratively Evaluate the Safety, Tolerability and Pharmacokinetics of DA-5223 Compared With DA-5223-R in Healthy Adult Subjects

Sponsor: Dong-A ST Co., Ltd.

View on ClinicalTrials.gov

Summary

This study will exploratively evaluate the safety, tolerability and pharmacokinetics of DA-5223 compared with DA-5223-R in healthy adult subjects

Official title: An Open-label, Randomized, Single-dose, Two-Cohort, Two-Period, Crossover Study to Exploratively Evaluate the Safety, Tolerability and Pharmacokinetics of DA-5223 Compared With DA-5223-R in Healthy Adult Subjects

Key Details

Gender

All

Age Range

19 Years - 55 Years

Study Type

INTERVENTIONAL

Enrollment

12

Start Date

2026-06-15

Completion Date

2026-07-05

Last Updated

2026-07-15

Healthy Volunteers

Yes

Conditions

Interventions

DRUG

DA-5223-R

once a day

DRUG

DA-5223-F

once a day

DRUG

DA-5223-M

once a day

Locations (1)

Bumin hospital

Gangseo-gu, Seoul, South Korea